Transgene persistence and cell turnover in the diarthrodial joint: Implications for gene therapy of chronic joint diseases

Molecular Therapy

Volumn 15, Issue 6, 2007, Pages 1114-1120

  Gouze, Elvire ^a   Gouze, Jean Noel ^a   Palmer, Glyn D ^b   Pilapil, Carmencita ^b   Evans, Christopher H ^b   Ghivizzani, Steven C ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; CELL TYPE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENE TRANSFER; IMMUNOREACTIVITY; LIGAMENT; MALE; NONHUMAN; PHENOTYPE; PROMOTER REGION; RAT; SYNOVIUM; TENDON; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; CELL LINE; CHRONIC DISEASE; DNA, COMPLEMENTARY; FIBROBLASTS; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; JOINT DISEASES; LENTIVIRUS; MALE; MICROSCOPY, FLUORESCENCE; RATS; RATS, NUDE; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SYNOVIAL MEMBRANE; TRANSGENES;

ANIMALIA;

EID: 34249334647     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300151     Document Type: Article

References (41)

1. Connell, L and McInnes, IB (2006). New cytokine targets in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 20: 865-878.
2. Abramson, SB, Attur, M and Yazici, Y (2006). Prospects for disease modification in osteoarthritis. Nat Clin Pract Rheumatol 2: 304-312.
3. McInnes, IB and Liew, FY (2005). Cytokine networks - towards new therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol 1 31-39.
4. Evans, CH, Ghivizzani, SC, Kang, R, Muzzonigro, T, Wasko, MC, Hemdon, JH et al. (1999). Gene therapy for rheumatic diseases. Arthritis Rheum 42: 1-16.
5. Evans, CH, Ghivizzani, SC and Robbins, PD (2006). Will arthritis gene therapy become a clinical reality? Nat Clin Pract Rheumatol 2 344-345.
6. Boyle, DL, Nguyen, KH, Zhuang, S, Shi, Y, McCormack JE, Chada, S et al. (1999). Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced Th2activity. Gene Ther 6 1911-1918.
7. Adriaansen, J, Kuhlman, RR, van Holten, J, Kaynor, C, Vervoordeldonk, MJ and Tak, PP (2006). Intraarticular interferon-β gene therapy ameliorates adjuvant arthritis in rats. Hum Gene Ther 17: 986-996.
8. Apparailly, F, Khoury, M, Vervoordeldonk, MJ, Adriaansen, J, Gicquel, E, Perez, N et al. (2005). Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints. Hum Gene Ther 16 426-434.
9. Bandara, G, Mueller, GM, Galea-Lauri, J, Tindal, MH, Georgescu, HI, Suchanek, MK et al. (1993). Intraarticular expression of biologically active interieukin 1-receptor-antagonist protein by ex vivo gene transfer. Prac Natl Acad Sci USA 90: 10764-10768.
10. Chan, JM, Villarreal, G, Jin, WN, Stepan, T, Burstein, H and Wahl, SM (2002). Intraarticular gene transfer of TNFR:FC suppresses experimental arthritis with reduced systemic distribution of the gene product. Mol Ther 6: 727-736.
11. Ghivizzani, SC, Lechman, ER, Kang, R, Tio, C, Kolls, J, Evans, CH et al. (1998). Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor a soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Prac Natl Acad Sci USA 95: 4613-4618.
12. Gauze, E, Pawliuk, R, Gauze, JN, Pilapil, C, Fleet, C, Palmer, GD et al. (2003). Lentiviral-mediated gene delivery to synovium: Potent intra-articular expression with amplification by inflammation. Mol Ther 7: 460-466.
13. Lechman, ER, Jaffurs, D, Ghivizzani, SC, Gambotto, A, Kovesdi, I, Mi, Z et al. (1999). Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J Immunol 163: 2202-2208.
14. Ma, Y, Thornton, S, Duwel, LE, Boivin, GP, Giannini, EH, Leiden, JM et al. (1998). Inhibition of collagen-incluced arthritis in mice by viral IL-10 gene transfer. J Immunol 161: 1516-1524.
15. Oligino, T, Ghivizzani, S, Wolfe, D, Lechman, E, Krisky, D, Mi, Z et al. (1999). Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis. Gene Ther 6: 1713-1720.
16. Zhang, HG, Xie, J, Yang, P, Wang, Y, Xu, L, Liu, D et al. (2000). Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor α and reduces arthritis. Hum Gene Ther 11: 2431-2442.
17. Lubberts, E, Joosten, LA, van Den Bersselaar, L, Helsen, MM, Bakker, AC, van Meurs, JB et al. (1999). Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 163: 4546-4556.
18. Smeets, RL, van de Loo, FA, Arntz, OJ, Bennink, MB, Joosten, LA and van den Berg, WB (2003). Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice. Gene Ther 10 1004-1011.
19. Nonomura, Y, Kohsaka, H, Nasu, K, Terada, Y, Ikeda, M and Miyasaka, N (2001). Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p21(Cip1) gene into the joints. Int Immunol 13: 723-731.
20. Woods, JM, Katschke, KJ, Valin, MV, Ruth, JH, Woodruff, DC, Amin, MA et al. (2001). IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J Immunol 166: 1214-1222.
21. Yao, Q, Wang, S, Gambotto, A, Glorioso, JC, Evans, CH, Robbins, PD et al. (2003). Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium. Gene Ther 10: 1055-1060.
22. Evans, CH, Ghivizzani, SC and Robbins, PD (2006). Gene therapy for arthritis: What next? Arthritis Rheum 54: 1714-1729.
23. Hung, GL, Galea-Lauri, J, Mueller, GM, Georgescu, HI, Larkin, LA, Suchanek, MK et al. (1994). Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther 1: 64-69.
24. Bandara, G, Robbins, PD, Georgescu, HI, Mueller, GM, Glorioso, JC and Evans, CH (1992). Gene transfer to synoviocytes: Prospects for gene treatment of arthritis. DNA Cell Biol 11: 227-231.
25. Tomita, T, Takeuchi, E, Tomita, N, Morishita, R, Kaneko, M, Yamamoto, K et al. (1999). Suppressed severity of collagen-incluced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum 42: 2532-2542.
26. Gauze, E, Pawliuk, R, Pilapil, C, Gauze, JN, Fleet, C, Palmer, GD et al. (2002). In vivo gene delivery to synovium by lentiviral vectors. Mol Ther 5: 397-404.
27. Khoury, M, Bigey, P, Louis-Plence, P, Noel, D, Rhinn, H, Scherman, D et al. (2006). A comparative study on intra-articular versus systemic gene electrotransfer in experimental arthritis. J Gene Med 8 1027-1036.
28. Lubberts, E, Joosten, LA, Van Den Bersselaar, L, Helsen, MM, Bakker, AC, Xing, Z et al. (2000). Intra-articular IL-10 gene transfer regulates the expression of collagen-incluced arthritis (CIA) in the knee and ipsilateral paw. Clin Exp Immunol 120: 375-383.
29. Sawchuk, SJ, Boivin, GP, Duwel, LE, Ball, W, Bove, K, Trapnell, B et al. (1996). Anti-T cell receptor monoclonal antibody prolongs transgene expression following adenovirus-mediated in vivo gene transfer to mouse synovium. Hum Gene Ther 7: 499-506.
30. Kim, JM, Ho, SH, Park EJ, Hahn, W, Cho, H, Jeong, JG et al. (2002). Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis. Arthritis Rheum 46: 793-801.
31. Ge, Y, Powell, S, Van Roey, M and McArthur, JG (2001). Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX. Blood 97: 3733-3737.
32. Xiao, W, Chirmule, N, Schnell, MA, Tazelaar, J, Hughes, JV and Wilson, JM (2000). Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors. Mol Ther 1: 323-329.
33. Riviere, C, Danos, O and Douar, AM (2006). Long-term expression and repeated administration of AAV type 1, 2, and 5 vectors in skeletal muscle of immunocompetent adult mice. Gene Ther 13: 1300-1308.
34. Heald, A, Pate, G and Anklesaria, P (2006). Clinical studies of intra-articular administration of a recombinant adeno-associated vector containing a TNF-α antagonist gene in inflammatory arthritis. Mol Ther 13: S419-S420.
35. Mohler, KM, Torrance, DS, Smith, CA, Goodwin, RG, Stremler, KE, Fung, VP et al. (1993). Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal enclotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151: 1548-1561.
36. Mohr, W, Beneke, G and Mohing, W (1975). Proliferation of synovial lining cells and fibroblasts. Ann Rheum Dis 34: 219-224.
37. Gauze, JN, Stoddart, MJ, Gauze, E, Palmer, GD, Ghivizzani, SC, Grodzinsky, AJ et al. (2004). In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. Methods Mol Med 100: 147-164.
38. Harms, JF, Budgeon, LR, Christensen, ND and Welch, DR (2002). Maintaining GFP tissue fluorescence through bone decalcification and long-term storage. Biotechniques 33: 1197-1200.
39. Edwards, JCW and Wilkinson, LS (1995). Immunohistochemistry of rheumatoid synovium. In: Henderson, B, Edwards, JCW and Pettipher, ER (eds). Mechanisms and Models in Rheumatoid Arthritis. Academic Press: London. pp. 133-150.
40. Zimmermann, T, Kunisch, E, Pfeiffer, R, Hirth, A, Stahl, HD, Sack, U et al. (2001). Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture-primary culture cells markedly differ from fourth-passage cells. Arthritis Res 3: 72-76.
41. Morales-Ducret, J, Wayner, E, Elices, MJ, Alvaro-Gracia, JM, Zvaifler NJ and Firestein, GS (1992). Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol 149: 1424-1431.